Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
36.0%
% of BBH's 27 holdings also in CANC
20.0%
% of CANC's 46 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 7.9% | 5.6% | 5.6% |
|
ILLUMINA INC | 4.2% | 3.5% | 3.5% |
 |
ARGENX SE ADR | 4.4% | 2.9% | 2.9% |
|
GILEAD SCIENCES INC | 8.0% | 2.9% | 2.9% |
|
EXACT SCIENCES CORP | 2.1% | 3.1% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to CANC
|
AMGEN INC | 15.3% |
|
VERTEX PHARMACEUTICALS INC | 9.7% |
|
GILEAD SCIENCES INC | 5.2% |
|
IQVIA HOLDINGS INC | 4.9% |
|
BIOGEN IDEC INC | 4.3% |
 |
ICON PLC | 4.2% |
|
MODERNA, INC. | 3.6% |
|
BIOMARIN PHARMACEUTICAL INC | 3.1% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% |
|
CHARLES RIVER LABORATORIES | 2.5% |
BBH Underweight Relative to CANC
|
MERCK & CO. INC. | -5.6% |
 |
DAIICHI SANKYO CO LTD | -4.0% |
 |
ASTRAZENECA PLC | -3.8% |
 |
NOVARTIS AG | -3.7% |
|
REVOLUTION MEDICINES, INC. | -3.1% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.7% |
|
CELLDEX THERAPEUTICS INC | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |
|
EXELIXIS INC | -2.4% |